京新药业：人工大血管项目已经进入临床试验阶段

Core Viewpoint - The company, Jingxin Pharmaceutical, has announced that its artificial large blood vessel project has entered the clinical trial phase [1] Group 1 - The artificial large blood vessel project is a significant development for the company, indicating progress in its research and development efforts [1]